Sun. October 05, 2008
-
The Daily Advertiser
October 5, 2008
He is employed by
Johnson & Johnson. Escorted by her
father, the bride wore an ivory silk dupioni A-line gown with cap sleeves. ...
Inquirer.net
October 5, 2008
One set up Mead Johnson, the nutraceutical firm and maker of Lactum, Enfa
milk brands and Sustagen; and two others grew
Johnson & Johnson, ...
Wall Street Journal Blogs
October 4, 2008
Last year,
Johnson & Johnson made a creative deal with NICE, the
UK body that decides what drugs are worth the money: J&J said it would cover the cost of ...
MarketWatch
October 4, 2008
AtTask's clients include Apple,
At&t,
Boeing, CBS,
Chevron,
Cisco Systems, GE,
Google, HBO,
Johnson & Johnson, Samsung, Toyota, Walt Disney, and Whirlpool. ...
CNNMoney.com
October 4, 2008
... but some of its biggest beneficiaries are the drug and device industries, which include
Pfizer Inc. (PFE),
Johnson & Johnson (JNJ) and Medtronic Corp. ...
Forbes
October 4, 2008
... by midafternoon shares of Schering-Plough were down 5.4 percent at $16.51,
Johnson & Johnson was down 1.7 percent at $16.61, and
Eli Lilly was down 1.8 ...
New York Times
October 4, 2008
It was at the Johnson apartment (as in Johnson & Johnson) on Park Avenue. As usual on such occasions, Paul stood apart, his back to a wall, observing. ...
Sydney Morning Herald
October 3, 2008
The products included Maggi Noodles, Glad aluminium foil, Kraft Biskits,
Johnson & Johnson Band-Aids, Colgate toothbrushes, Matchbox
toy cars and MTV ...
Pharmalot
October 3, 2008
Among the meds -
Novartis's Triaminic;
Johnson & Johnson's Tylenol and PediaCare; Wyeth's Dimetapp and Procter & Gamble's NyQuil. ...
CNNMoney.com
October 3, 2008
... but some of its biggest beneficiaries are the drug and device industries, which include
Pfizer Inc. (PFE),
Johnson & Johnson (JNJ) and Medtronic Corp. ...
IT Business Net
October 3, 2008
AtTask's clients include Apple,
At&t,
Boeing, CBS,
Chevron,
Cisco Systems, GE,
Google, HBO,
Johnson & Johnson, Samsung, Toyota, Walt Disney, and Whirlpool.
Motley Fool
October 3, 2008
Many investors see big, boring blue chips like
Johnson & Johnson and Procter & Gamble (
nyse: PG) as great places to be right now. With a beta of 0.38, ...
Bloomberg
October 1, 2008
By Andrew Harris Oct. 1 (Bloomberg) -- Johnson & Johnson was awarded $629 million in interest in its 11-year patent battle with Medtronic Inc. and Boston ...
KLAS-TV
October 1, 2008
based Centocor, a unit of Johnson & Johnson. Abbott shares fell $1.29, or 2.3% to $56.64 Thursday afternoon; Amgen fell $1.73, or 2.7 percent, to $61.37; ...
Terre Haute Tribune Star
October 1, 2008
... Honda,
Honeywell/UOP, Ingersoll
Rand,
Johnson & Johnson, Kroger Co.,
Marathon Oil,
Microsoft, Milliken & Co., National Instruments,
Northrop Grumman, ...
MarketWatch
October 1, 2008
The second-largest player was Beiersdorf AG with
Johnson & Johnson in third place. - Discover the major quantitative trends affecting the Skincare
markets. ...
Bloomberg
October 1, 2008
30 (Bloomberg) -- Johnson & Johnson said a US judge has awarded the company $1.2 billion in an 11-year patent battle with Medtronic Inc. and Boston ...
Sify
September 30, 2008
Johnson & Johnson dominates the
baby-care
market in
India, with 85% market share, followed by
Wipro. A Wipro Consumer Care spokesperson said the size of the ...
Town Hall
September 30, 2008
Johnson & Johnson is a Motley Fool Income Investor choice. Cemex and Tata Motors are Global Gains picks. Cemex and Apple are Stock
advisor recommendations. ...
Hindu
September 30, 2008
... on Tuesday said it has entered into a drug discovery and development collaboration with Ortho McNeil Janssen Pharmaceuticals, a Johnson & Johnson arm. ...
Medical News Today (press release)
September 30, 2008
Johnson & Johnson Vision Care, Inc., sponsored the survey although subjects were unaware of the sponsor's identity. The sample was randomly selected from a ...
Business Standard
September 29, 2008
Someone can come from Johnson & Johnson, or Tata. They help in refining and developing our sales and marketing capabilities. That is the primary reason. ...
Food Consumer
September 29, 2008
Depending on the marketer, the drug is also called Procrit by Johnson & Johnson and Epogen by Amgen. The drug, a member of a class called ...
eFluxMedia
September 29, 2008
By Anna Boyd Results of a study undergone by German
scientists revealed that stroke patients given Amgen and
Johnson & Johnson's anemia drug Eprex might ...
Motley Fool
September 29, 2008
With its marketing partner
Johnson & Johnson (
nyse: JNJ), Vertex found that patients can get the same benefits from taking the drug twice a day in higher ...
BusinessWeek
September 29, 2008
Pfizer,
Merck and
Johnson & Johnson all are components of the Dow industrials average. In the same period, Wyeth shares dropped the most, ...
Seeking Alpha
September 28, 2008
Likewise, strong
companies like
Johnson & Johnson experienced periodic dips, but entrepreneurial investors keep an eye on the long-term trend. ...
Rochester Democrat and Chronicle
September 28, 2008
Since the start of this year, B&L has a new CEO in Gerald Ostrov, a former top vision care executive at competitor Johnson & Johnson, and a new executive ...
Newsday
September 28, 2008
Top stock holdings are Forest Oil, Crown Holdings,
VeriSign,
Johnson & Johnson and Nestlé. This "no-load" (no sales charge) fund requires a $5000 minimum ...
National Post
September 27, 2008
as well as Johnson & Johnson favourites from Phisoderm, Band-Aid, Listerine, Aveeno, Purell, Visine, Neutrogena and Almay. From 10am daily with free parking ...
CNNMoney.com
September 27, 2008
The agency also sent three so-called untitled letters to Johnson & Johnson (JNJ), which makes Concerta, and to two other ADHD drug makers. ...
New York Times
September 27, 2008
Johnson & Johnson also sells epoetin alfa under the name Procrit. Amgen sells a version under the name Epogen. The blockbuster drugs are part of a class ...
Reuters
September 26, 2008
Such drugs -- from
companies including Amgen,
Genentech,
Pfizer and
Johnson & Johnson -- are used to treat complex illnesses including
cancer and rheumatoid ...
Reuters
September 26, 2008
WASHINGTON (Reuters) - More patients died after treatment with a Johnson & Johnson anemia drug in a study testing whether the medicine could improve brain ...
Motley Fool
September 26, 2008
The drug also faces competition from rival hepatitis drugs being developed, including one by
Johnson & Johnson (
nyse: JNJ) and Medivir. ...
Pharmalot
September 26, 2008
In
the US, epoetin alfa is marketed as Procrit by
Johnson & Johnson, and Epogen by Amgen, and in
Germany, marketed as Eprex by J&J. ...
Forbes
September 26, 2008
The latest drug to be part of an early communication is Johnson & Johnson's Eprex, or epoetin alfa, which is approved for the treatment of anemia and is ...
